An Analysis of Insmed Inc (INSM)’s Potential Price Growth

Insmed Inc’s recently made public that its Chair and CEO Lewis William unloaded Company’s shares for reported $0.7 million on Jul 15 ’25. In the deal valued at $102.37 per share,6,830 shares were sold. As a result of this transaction, Lewis William now holds 233,924 shares worth roughly $23.99 million.

Then, Smith Michael Alexander sold 933 shares, generating $95,642 in total proceeds. Upon selling the shares at $102.51, the Chief Legal Officer now owns 66,394 shares.

Before that, Smith Michael Alexander sold 748 shares. Insmed Inc shares valued at $72,115 were divested by the Chief Legal Officer at a price of $96.41 per share. As a result of the transaction, Smith Michael Alexander now holds 67,327 shares, worth roughly $6.91 million.

Jefferies initiated its Insmed Inc [INSM] rating to a Buy in a research note published on May 13, 2025; the price target was $105. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Truist began covering INSM with “Buy” recommendation on April 23, 2024. Wolfe Research started covering the stock on February 15, 2024. It rated INSM as “an Outperform”.

Price Performance Review of INSM

On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -1.55% to $102.56. Over the last five days, the stock has gained 4.46%. Insmed Inc shares have risen nearly 31.51% since the year began. Nevertheless, the stocks have risen 48.54% over the past one year. While a 52-week high of $106.83 was reached on 06/25/25, a 52-week low of $60.40 was recorded on 04/09/25.

Levels Of Support And Resistance For INSM Stock

The 24-hour chart illustrates a support level at 101.63, which if violated will result in even more drops to 100.71. On the upside, there is a resistance level at 104.24. A further resistance level may holdings at 105.93.

How much short interest is there in Insmed Inc?

A steep rise in short interest was recorded in Insmed Inc stocks on 2025-06-13, dropping by -4.82 million shares to a total of 11.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 16.47 million shares. There was a decline of -41.35%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on December 08, 2023 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $55 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.